NEWS

WIRES

OTHER

Friday, March 31st Stock Trading Alert

eLocity's stocks to watch for today are -- Synova Healthcare Group. (OTC BB: SNVH), ATI Technologies Inc. (NASDAQ: ATYT), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA).

Investors, take a look at an emerging healthcare company, Synova Healthcare Group (OTC BB: SNVH). Through its two wholly owned subsidiaries, Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc., the company distributes rapid, non-invasive medical diagnostics for over-the-counter retail use and directly to health care providers for point of care use in the clinical setting.

Thursday morning Synova Healthcare, Inc. announced that starting in May, its non-invasive test developed to assist women in the diagnosis and appropriate treatment of vaginal infections, Fem-V(TM), will be available at Rite Aid stores. Synova said that this easy-to-use at-home test for the millions of American women who experience vaginal infections annually will help determine if an over-the-counter treatment may be considered, or if they should seek treatment from a healthcare professional.

Company President, Mr. David Harrison, said the company is very pleased to have Fem-V(TM) available for sale at Rite Aid stores, commenting, "Fem- V(TM) represents an important breakthrough in assisting women to determine the most appropriate course of treatment for their vaginal infections. We hope to encourage women who are suffering from the symptoms of vaginal infections to 'TEST BEFORE YOU TREAT,' and increase the likelihood of a successful outcome."

According to Synova, there is little awareness among women concerning the appropriate diagnosis of vaginal infections, which can lead to ineffective and inappropriate treatment that could result in serious health risks, including pelvic inflammatory disease. Synova said that the Fem-V(TM) Vaginal Infection Test allows women to determine the likely cause of their symptoms prior to treatment.

Synova Healthcare Group. (OTC BB: SNVH) closed Thursday at $2.15 a share.

Other stocks to watch:

ATI Technologies Inc. (NASDAQ: ATYT) announced financial results for the second quarter Thursday, reporting GAAP net income of 34.14 million, or $0.13 per share, compared to $57.19 million, or $0.22, per share in the same period last year.

ATYT closed Thursday's regular trading session at $17.05.

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced Thursday that the company has increased its equity ownership in Tianjin Hualida Biotechnology Co., Ltd. in Tianjin to 60% from 45%.

TEVA closed Thursday's regular trading session at $40.86.

About eLocity Inc: eLocity owns and operates three financial websites for investors.

-PennyPicks.com, http://www.pennypicks.com/. Featuring active message boards for the penny stock trader, rumors and more.

-StockGrid.com, http://www.stockgrid.com/. Visit this site for our daily top stock "GRID Makers." We rank stocks on volume, message board activity, sentiment and trend forecast.

-Bell2Bell.com, http://www.bell2bell.com/. Bell2Bell features news stories, rumors, the InvestBoard and more.

Sign up for FREE at any of the sites above.

The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, is here after referred to as "the company." The company received compensation for this service for SNVH (Public Company). The compensation is forty thousand dollars from a non-affiliated third party, Equity Alliance, Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.

The company relies exclusively on information gathered on the Public Company, such as public filings, press releases and its web sites. Investors should use the information contained in this publication as a starting point for conducting additional research on the Public Company in order to allow the investor to form his or her own opinion regarding the Public Company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the Public Company that this newsletter is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.

The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Distributed by Market Wire